Search
for
Sort by
Research 121–150 of 512
- Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
- RP-HPLC-Based Stability-Indicating Analytical Method for Concurrent Determination of Finasteride and Tadalafil: Development and Validation
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Optimized Nanostructured Lipid Carriers for Dutasteride Delivery: Improving Therapeutic Efficiency and Minimizing Adverse Effects
- UTILIDADES DE LA ESPIRONOLACTONA COMO FÁRMACO ANTIANDROGÉNICO
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Oral Presentations
- Prognosis and Management of Congenital Hair Shaft Disorders with Fragility—Part I
- Sequential small-molecule therapy for lymphocytic cicatricial alopecia: A multicenter prospective cohort pilot study
- The Use of Anabolic Steroids by Bodybuilders in the State of Sergipe, Brazil
- Skin applications of cannabidiol: sources, effects, delivery systems, marketed formulations and safety
- Medikamentöse Therapie des benignen Prostatasyndroms
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- ENZYMES
- Enzymes
- Molecular Targets in Modern Cosmetic Science
- Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Systemic Antifungals
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review
- 294 Extensive alopecia areata is reversed by IL-12/23p40 cytokine antagonism
- Netherton Syndrome Associated with Growth Hormone Deficiency
- Assessment of Alopecia Areata Disease Severity in Pediatric Patients
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- The Rotterdam Study: 2018 update on objectives, design and main results
- The Rotterdam Study: 2016 objectives and design update
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism